PRETTA, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 16.700
NA - Nord America 675
AS - Asia 143
AF - Africa 3
OC - Oceania 2
SA - Sud America 1
Totale 17.524
Nazione #
IT - Italia 16.454
US - Stati Uniti d'America 663
SE - Svezia 117
CN - Cina 72
NL - Olanda 28
IN - India 26
DE - Germania 21
GB - Regno Unito 18
FI - Finlandia 16
SG - Singapore 14
FR - Francia 12
CA - Canada 8
VN - Vietnam 8
BE - Belgio 7
HK - Hong Kong 7
IE - Irlanda 7
ES - Italia 5
IR - Iran 4
TH - Thailandia 4
UA - Ucraina 4
AT - Austria 3
BZ - Belize 3
GR - Grecia 3
JP - Giappone 3
AU - Australia 2
CH - Svizzera 2
MU - Mauritius 2
AE - Emirati Arabi Uniti 1
BR - Brasile 1
IL - Israele 1
KR - Corea 1
MO - Macao, regione amministrativa speciale della Cina 1
PT - Portogallo 1
RO - Romania 1
RU - Federazione Russa 1
SC - Seychelles 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 17.524
Città #
Cagliari 16.312
Nyköping 104
Chandler 89
Fairfield 85
Ashburn 66
New York 38
Houston 35
Boardman 32
Wilmington 32
Shanghai 31
Rome 30
Seattle 30
Cambridge 28
Woodbridge 26
Amsterdam 22
Pune 21
San Diego 18
Boston 17
Helsinki 15
Dong Ket 8
Toronto 8
Paris 7
London 6
Dublin 5
Jacksonville 5
Los Angeles 5
Menlo Park 5
Ann Arbor 4
Beijing 4
Buffalo 4
Dearborn 4
Hefei 4
Hong Kong 4
La Maddalena 4
Nanjing 4
Naples 4
Romainville 4
Sestu 4
Belize City 3
Brussels 3
Pamplona 3
Peristeri 3
San Cipriano d'Aversa 3
San Francisco 3
Sassari 3
Shenzhen 3
Turin 3
Vienna 3
Washington 3
Centro 2
Delhi 2
Don Mueang 2
Enna 2
Godo 2
Guangzhou 2
Islington 2
Leuven 2
Livorno 2
Milan 2
Molenbeek-Saint-Jean 2
Nakano 2
New Bedfont 2
Norwalk 2
Olbia 2
Piacenza 2
Redwood City 2
Salerno 2
San Giorgio a Cremano 2
Sydney 2
Xian 2
Zhengzhou 2
Acton 1
Alexandria 1
Amgaon 1
Ankara 1
Assèmini 1
Augusta 1
Basel 1
Bergamo 1
Bilbao 1
Borås 1
Cavenago di Brianza 1
Chandigarh 1
Dubai 1
Ebisu 1
Edinburgh 1
Exeter 1
Frankfurt am Main 1
Frattamaggiore 1
Gela 1
Hamburg 1
Heidelberg 1
Hounslow 1
Kilburn 1
Lecce 1
Lisbon 1
Lviv 1
Mahé 1
Miami Beach 1
Moscow 1
Totale 17.230
Nome #
BRAF-mutant colorectal cancer, a different breed evolving 2.503
Molecular-biology-driven treatment for metastatic colorectal cancer 2.105
Colorectal cancer early detection in stool samples tracing CPG islands methylation alterations affecting gene expression 1.724
New therapeutic targets in pancreatic cancer 1.300
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients? 1.247
Colorectal cancer promoter methylation alteration affects the expression of glutamate ionotropic receptor AMPA type subunit 4 alternative isoforms potentially relevant in colon tissue 689
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 599
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 473
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment 472
Molecular-driven treatment for biliary tract cancer: the promising turning point 460
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 419
Uncovering key targets of success for immunotherapy in pancreatic cancer 408
Balance between the stem cell marker CD44 and CDX2 expression in colorectal cancer 379
Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab 360
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 352
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 344
BRCA-mutant pancreatic ductal adenocarcinoma 334
Immune Checkpoint Inhibitors in the Treatment of HCC 334
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 307
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 279
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 265
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 248
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters 235
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer 227
Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib 194
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients 182
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 172
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 170
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression 164
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma 139
Primary adrenal insufficiency induced by immune checkpoint inhibitors: Biological, clinical, and radiological aspects 124
Understanding the user's point of view: when the doctor gets sick with cancer and seeks help 76
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapy 65
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 59
null 47
CDK4/6 inhibition in hormone receptor-positive/HER2-negative breast cancer: Biological and clinical aspects 44
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 38
Fibroblast growth factor receptors as targets for anticancer therapy in cholangiocarcinomas and urothelial carcinomas 36
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma 35
null 27
Immunotherapy and Cancer: The Multi-Omics Perspective 21
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score 10
Totale 17.666
Categoria #
all - tutte 26.926
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.926


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201941 0 0 0 0 0 0 0 0 0 0 19 22
2019/2020893 47 19 6 12 254 210 182 35 20 33 23 52
2020/20214.569 78 143 108 1.502 869 530 186 310 140 289 252 162
2021/20222.042 127 87 24 97 119 135 96 187 170 229 334 437
2022/20235.088 400 643 563 372 376 438 226 395 436 543 460 236
2023/20244.959 262 188 191 285 445 895 977 435 378 359 544 0
Totale 17.666